View Older Stories

Jan 20, 2026 02:05AM Canaccord Genuity Downgrades Penumbra (PEN) to Hold

Jan 16, 2026 08:53AM UBS Downgrades Penumbra (PEN) to Neutral

Jan 16, 2026 08:50AM Jefferies Downgrades Penumbra (PEN) to Hold

Jan 16, 2026 08:41AM Needham Downgrades Penumbra (PEN) to Hold

Jan 16, 2026 04:33AM Nephron Downgrades Penumbra (PEN) to Hold

Jan 16, 2026 02:55AM Baird Downgrades Penumbra (PEN) to Neutral

Jan 16, 2026 02:12AM Leerink Partners Downgrades Penumbra (PEN) to Market Perform

Jan 16, 2026 12:46AM Truist Securities Downgrades Penumbra (PEN) to Hold

Jan 15, 2026 04:09PM Citi Downgrades Penumbra (PEN) to Neutral

Jan 15, 2026 04:07PM BTIG Downgrades Penumbra (PEN) to Neutral

Jan 15, 2026 11:37AM Wells Fargo Downgrades Penumbra (PEN) to Equal Weight

Jan 15, 2026 09:54AM Morgan Stanley on Boston Scientific (BSX): 'Stock is looking too cheap and has clear catalysts'

Jan 15, 2026 09:30AM William Blair Downgrades Penumbra (PEN) to Market Perform

Jan 15, 2026 09:26AM Piper Sandler Downgrades Penumbra (PEN) to Neutral

Jan 15, 2026 08:16AM Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down

Jan 15, 2026 07:01AM Penumbra reports preliminary Q4 2025 revenue of $383-385 million

Jan 9, 2026 07:24AM Penumbra (PEN) PT Raised to $379 at Leerink Partners

Jan 5, 2026 11:00PM BofA’s six MedTech picks for 2026 on strong earnings growth

Dec 18, 2025 01:09AM JPMorgan Upgrades Penumbra (PEN) to Overweight

Dec 17, 2025 04:59AM Penumbra (PEN) PT Raised to $388 at Needham

Nov 6, 2025 06:17AM Needham Reiterates Buy Rating on Penumbra (PEN)

Nov 6, 2025 05:02AM Penumbra (PEN) PT Raised to $312 at Truist Securities

Nov 6, 2025 05:00AM Penumbra (PEN) PT Raised to $355 at Canaccord Genuity

Nov 6, 2025 03:56AM Penumbra (PEN) PT Raised to $286 at Evercore ISI

Nov 3, 2025 03:00PM Penumbra trial shows blood clot removal device improves pulmonary embolism outcomes

Oct 27, 2025 09:01AM Penumbra trial shows thrombectomy device outperforms standard treatment

Oct 8, 2025 05:39AM Needham Upgrades Penumbra (PEN) to Buy

Sep 8, 2025 06:40AM Needham Reiterates Hold Rating on Penumbra (PEN)

Sep 2, 2025 06:18AM Evercore ISI Starts Penumbra (PEN) at Outperform

Aug 27, 2025 09:02AM Penumbra promotes Shruthi Narayan to company president

Jul 30, 2025 10:02AM Penumbra (PEN) PT Raised to $335 at UBS

Jul 30, 2025 08:04AM Penumbra (PEN) PT Lowered to $325 at RBC Capital

Jul 30, 2025 07:15AM Penumbra (PEN) PT Raised to $350 at Canaccord Genuity

Jul 29, 2025 04:15PM Penumbra, Inc. (PEN) Tops Q2 EPS by 3c, provides guidance

Jul 2, 2025 08:00AM BTIG names top large-cap picks for second half of 2025

May 9, 2025 11:10AM Penumbra stock surges on approval hopes

Apr 24, 2025 11:03AM Penumbra (PEN) PT Raised to $330 at UBS

Apr 24, 2025 10:24AM Penumbra (PEN) PT Raised to $318 at Stifel

Apr 24, 2025 05:28AM Penumbra (PEN) PT Raised to $320 at BTIG

Apr 23, 2025 04:11PM Penumbra, Inc. (PEN) Tops Q1 EPS by 16c, reiterates guidance

Apr 3, 2025 09:21AM RBC Capital Assesses U.S. Tariff Impact Across Industries

Mar 14, 2025 07:33AM BofA Securities Starts Penumbra (PEN) at Buy

Mar 10, 2025 11:14AM RBC Capital: 'Opportunities Across MedTech Stocks'

Feb 21, 2025 04:07PM Penumbra, Inc. (PEN) announces retirement of Don Kassing from Board

Feb 19, 2025 09:24AM Penumbra (PEN) PT Raised to $320 at UBS

Feb 19, 2025 06:47AM Penumbra (PEN) PT Raised to $340 at Canaccord Genuity

Feb 19, 2025 05:16AM Penumbra (PEN) PT Raised to $308 at BTIG, Top Pick

Feb 18, 2025 04:08PM Penumbra, Inc. (PEN) Tops Q4 EPS by 7c, provides guidance

Jan 21, 2025 06:00PM MedTech sector outlook for 2025: Truist Securities

Jan 21, 2025 01:00AM UBS Starts Penumbra (PEN) at Buy

View Older Stories